News & Articles
PR: Vagus Nerve Stimulation Associated with Fewer Deaths in Hospitalized COVID-19 Patients, Dec 2, 2020
OVERLAND PARK, KANSAS, UNITED STATES, December 2, 2020 /EINPresswire.com/ — Nemechek Technologies is proud to announce publication of a peer-reviewed research article by its CEO, Patrick Nemechek
OVERLAND PARK, Kan., July 28, 2020 /PRNewswire/ — Nemechek Technologies has applied to the World Health Organization (WHO) for Emergency Use Listing (EUL) of its Vitality Smartcable device. In
OVERLAND PARK, KS, July 20, 2020 — Nemechek Technologies has applied to the FDA for an Emergency Use Authorization (EUA) for its Vitality Smartcable device. Originally
Vagus Nerve Stimulation (VNS) Clinical Trial Begins Enrolling COVID-19 Patients OVERLAND PARK, Kan., July 9, 2020 /PRNewswire/ — COVID-19 patients have begun enrolling in an interventional clinical trial at
Is Bio-Electric Medicine the Next Frontier of Therapy for Coronavirus Victims? Just Published – Dr. Patrick Nemechek proposes new technology to suppress COVID-19 cytokine storm.